Endocrinology, Vol 131, 2643-2648, Copyright © 1992 by Endocrine Society

ARTICLES

Calbindin-D9K gene expression in the lung of the rat. Absence of regulation by 1,25-dihydroxyvitamin D3 and estrogen

JM Dupret, F L'Horset, C Perret, JF Bernaudin and M Thomasset
INSERM U 120, Hopital Robert Debre, Paris, France.

Calbindin-D9K (CaBP9K) is classically considered to be the molecular expression of 1,25-dihydroxyvitamin D3. The hormone is known to regulate the rat CaBP9K gene in duodenal tissue at transcriptional and posttranscriptional levels. This study shows that the CaBP9K gene is expressed in the rat lung, and that this expression is probably not vitamin D- or estrogen-dependent. The CaBP9K gene is not expressed in alveolar macrophages, but CaBP9K messenger RNA (mRNA) was localized by in situ hybridization in alveolar epithelial cells. CaBP9K mRNA was detected as early as the 20th day of gestation. The quantity of CaBP9K mRNA gradually increased during growth, from 1-77 days after birth, whereas the CaBP9K concentration dramatically increased from day 19 to day 20 of gestation. Vitamin D-deficient male rats (8 weeks old) were given a single injection of 1,25-dihydroxyvitamin D3 (650 pmol/100 g body wt) and killed 1 h and 24 h after injection. The hormonal treatment resulted in a rise in duodenal CaBP9K mRNA, but no significant change in lung extracted CaBP9K mRNA. Mature ovariectomized rats were injected with 17 beta-estradiol (0.5 microgram/100 g body wt) and killed 24, 48, and 72 h later. The CaBP9K mRNA concentration in the uterus was markedly dependent on estrogen; that of the lung was not. The factors regulating the CaBP9K gene expression in the lung remain to be determined.

This article has been cited by other articles:

				V. H. Dang, T. H. Nguyen, K.-C. Choi, and E.-B. Jeung A Calcium-Binding Protein, Calbindin-D9k, Is Regulated through an Estrogen-Receptor Mediated Mechanism following Xenoestrogen Exposure in the GH3 Cell Line Toxicol. Sci., August 1, 2007; 98(2): 408 - 415. [Abstract] [Full Text] [PDF]

				V. H. Dang, K.-C. Choi, and E.-B. Jeung Tetrabromodiphenyl Ether (BDE 47) Evokes Estrogenicity and Calbindin-D9k Expression through an Estrogen Receptor-Mediated Pathway in the Uterus of Immature Rats Toxicol. Sci., June 1, 2007; 97(2): 504 - 511. [Abstract] [Full Text] [PDF]

				K. C Luu, G. Y. Nie, A. Hampton, G.-Q. Fu, Y.-X. Liu, and L. A Salamonsen Endometrial expression of calbindin (CaBP)-d28k but not CaBP-d9k in primates implies evolutionary changes and functional redundancy of calbindins at implantation Reproduction, October 1, 2004; 128(4): 433 - 441. [Abstract] [Full Text] [PDF]

				K. Tatsumi, T. Higuchi, H. Fujiwara, T. Nakayama, K. Itoh, T. Mori, S. Fujii, and J. Fujita Expression of calcium binding protein D-9k messenger RNA in the mouse uterine endometrium during implantation Mol. Hum. Reprod., February 1, 1999; 5(2): 153 - 161. [Abstract] [Full Text] [PDF]

				Y. C. Li, A. E. Pirro, and M. B. Demay Analysis of Vitamin D-Dependent Calcium-Binding Protein Messenger Ribonucleic Acid Expression in Mice Lacking the Vitamin D Receptor Endocrinology, March 1, 1998; 139(3): 847 - 851. [Abstract] [Full Text] [PDF]

				B. Romagnolo, F. Cluzeaud, M. Lambert, S. Colnot, A. Porteu, T. Molina, M. Tomasset, A. Vandewalle, A. Kahn, and C. Perret Tissue-specific and Hormonal Regulation of Calbindin-D9K Fusion Genes in Transgenic Mice J. Biol. Chem., July 12, 1996; 271(28): 16820 - 16826. [Abstract] [Full Text] [PDF]